TrialEuropean journal of nuclear medicine and molecular imaging2018

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.

Ruth Ladenstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.